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It is widely agreed that neuroimaging is not required for all 
children with seizures.1-4 Suggested selective indications for 
neuroimaging include partial seizures because of a higher 
prevalence of abnormalities, including tumours, associated 
with such seizures.1-4 An association of partial seizures with 
treatable lesions has been observed in adults,5,6 but partial 
seizures are more common in children than in adults5,7 and the 
clinical spectrum and aetiology of seizures in children are very 
different. It has been found that childhood partial seizures are 
more likely to involve abnormal neuroimaging.8-10
When neuroimaging is required, magnetic resonance 
imaging (MRI) is regarded as the investigation of choice in 
most circumstances in industrialised countries.1-4,11 However 
access to MRI in low- and middle-income countries is 
extremely limited. Computed tomography (CT) is available in 
some settings, but availability remains limited.
Several studies10,12,13 have examined the diagnostic yield 
of CT in children with a first partial seizure. Although 4% of 
children required further diagnostic workup in one study,12
it is not reported whether this work-up was followed by 
therapeutically important decisions. In another study,13 14 (21%) 
of 66 children who had CT performed had abnormal findings. 
Two were of ‘immediate therapeutic significance’, but both 
findings were predictable from clinical history or examination.  
The third study10 found abnormalities in 19 (18%) of 107 CT 
scans, but it was not reported whether these abnormalities had 
been suspected clinically. All three studies were retrospective 
or contained large retrospective elements. This is likely to 
have led to unrepresentative samples of children receiving 
scans and potential biases in the extraction of clinical data 
from clinical records, particularly in assessing changes in 
clinical management. The importance of partial seizures, or 
of specific clinical features in such seizures, as predictors of 
therapeutically important CT findings is therefore not clear.
These three studies were conducted in industrialised 
countries and have limited applicability to areas of the 
developing world with a high prevalence of parasitic brain 
cysts and tuberculosis (TB) and limited access to CT. Of a 
group of 23 neurologically normal Indian children with partial 
seizures (65% with first seizures), 35% had abnormal CT scans, 
but the patients were a selected group and not consecutive 
because of cost constraints.15
In Cape Town a strong impression was gained that in 
children over 2 years of age with a single partial seizure and 
no underlying neurological deficit, the overwhelming majority 
of therapeutically important CT abnormalities were those of 
neurocysticercosis or TB. The CT features of neurocysticercosis 
and TB are often difficult to differentiate, and our practice had 
been to exclude TB (using chest radiography and skin testing) 
and to manage the remaining patients for neurocysticercosis. 
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Objectives. To determine the diagnostic yield of computed 
tomography (CT) of the head in children presenting for 
the first time with partial seizures in a region with a high 
prevalence of tuberculosis and neurocysticercosis.
Design. Prospective cohort study.
Setting. The secondary-level ambulatory service of Red Cross 
Children’s Hospital, Cape Town.
Subjects. Children aged 6 months - 12 years with a first partial 
seizure.
Outcome measures. Abnormal CT findings; clinically 
unsuspected abnormal CT findings. 
Results. Of 118 enrolled children, CT findings were available 
for 94 (80%). Sixteen (33%) of 49 children scheduled to return 
later for an initial CT scan failed to do so. Thirty-two scans 
(34%) were reported normal, 45 (48%) showed single or 
multiple granulomas, and 17 (18%) showed other findings. All 
8 children with persistent specific CT findings were suspected 
of having the condition before CT scan. Of 68 cases with 
prospectively recorded clinically expected CT findings, normal 
scans were expected in 2 cases (3%) and occurred in 33 cases 
(49%).
Conclusions. Routine CT scan for children presenting with 
a first partial seizure in an area with a high prevalence 
of neurocysticercosis failed to identify findings other 
than neurocysticercosis that meaningfully altered clinical 
management. Assuming a 70% relative reduction of seizures 
with albendazole treatment for neurocysticercosis, routine CT 
scanning in the study population would require 11 scans and 5 
courses of albendazole to prevent 1 child from having seizures, 
compared with no CT scans and 11 courses of albendazole 
with blanket use of albendazole.
S Afr Med J 2006; 96: 941-944.
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At the time that the study was planned there was little 
convincing evidence to support the use of albendazole for 
neurocysticercosis. If there were no other clinically significant 
causes of the seizures in this group of children, it would then 
have been rational to exclude TB and manage all remaining 
patients conservatively, as if they had normal scans or 
neurocysticercosis, without performing CT. Such a policy 
would have had considerable beneficial resource implications, 
particularly for patients referred long distances for scans, 
and would free up limited CT facilities for more fruitful 
investigations.
Objective
To determine the diagnostic yield of head CT scans in children 
presenting for the first time with partial seizures in a region 
with a high prevalence of TB and neurocysticercosis.
Methods
Participants
Children aged 6 months - 12 years presenting for the first 
time with partial seizure to the secondary-level ambulatory 
service of Red Cross Children’s Hospital, Cape Town, were 
prospectively enrolled from 12 October 1999 to 31 December 
2002. Details of history and clinical examination, as listed in 
Table I, were recorded by the clinician caring for the child on 
a pro forma record sheet adapted to form part of the routine 
clinical record. In children whose CT findings were not already 
known the clinicians also recorded their expected CT findings. 
The investigators extracted the CT findings from the formal 
radiological report, and extracted details of actual clinical 
management and follow-up from the routine clinical notes. 
CT findings were categorised as normal, granuloma (single 
or multiple, with or without calcification), incidental findings 
without clinical significance (reported as such or ignored by 
the clinicians), findings of uncertain significance, and specific 
findings other than granuloma.
Agreement between the clinicians’ expected findings and 
the actual CT findings was adjusted for chance agreement 
using the kappa statistic. A planned multiple regression 
analysis to identify clinical predictors of specific scan findings 
was not performed because it was judged not to be clinically 
meaningful, given the small number and very heterogeneous 
nature of findings other than granuloma.
Ethical approval
The study was approved by the Research Ethics Committee of 
the University of Cape Town. 
Results
One hundred and eighteen children were enrolled. CT scan 
findings were available for 94 (79.7%). The reasons for loss 
to follow-up of other participants are shown in Fig. 1, and 
were mainly due to missed appointments for the CT scan. The 
clinical characteristics of children for whom CT scans were 
performed are shown in Table I.
Of the 95 children who had CT scans, 32 (34%) were reported 
as normal, 45 (48%) showed single or multiple granulomas, 
and 17 (18%) showed other findings, while in 1 case no record 
of the findings was traceable. A breakdown of the findings is 
shown in Table II.
Table I. Characteristics of children with CT scan reports
N (%)
Age in months (median, IQ range) 94 64, 33 - 99
Gender (male 94 46 (49)
Complex seizure 85 68 (80)
Right-sided seizure 92 47 (51)
Duration of seizure in minutes (median, 
IQ range) 73
30, 10 - 60
Fever (reported by caregiver) 93 16 (17)
Preceding headache 87 17 (20)
Preceding vomiting 91 20 (22)
Tuberculosis contact 92 12 (13)
Developmental delay 91 5 (6)
Developmental regression 92 0
Recent change in behaviour or school 
performance
91 1 (1)
Papilloedema (when fundi seen) 42 0
Neck stiffness 91 5 (6)
Cranial nerve palsy 93 5 (5)
Hemiplegia 93 6 (6)
Cranial nerve palsy or hemiplegia 93 9 (10)
Fig. 1. Lost to follow-up.
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There were findings of uncertain significance on 4 scans 
that resolved on follow-up. These were ill-defined lesions that 
disappeared or were judged insignificant after repeat CT scan. 
Of the 8 children with specific CT findings, all were suspected 
of having the condition before CT scan (Table III). 
Of 68 cases where the clinician recorded the expected CT 
finding (normal, granuloma or other) and a CT report was 
available, expected findings agreed with CT findings in 31 
cases (46%). Chance-adjusted agreement (kappa) was 16% (95% 
confidence interval (CI): -2 - 34%) (Table IV). A normal scan 
was expected in 2 cases (3%) and occurred in 33 cases (49%). 
‘Other’ findings were expected in 17 cases (25%), and occurred 
in 5 cases (7%). Granuloma was expected in 49 cases (72%), and 
occurred in 30 cases (44%). 
Of the 49 children scheduled to return at a later date for the 
initial CT scan, 16 (33%) failed to do so. 
Discussion
None of the children in this study had a meaningfully 
abnormal CT finding other than neurocysticercosis that was 
not clinically suspected before CT. Routine CT scanning 
did not meaningfully change the clinical management of 94 
children aged 6 months - 12 years with a first presentation for 
partial seizure. From this sample the upper 95% confidence 
limit for such management change is 3.85%. That is, even at 
the highest CT yield that might plausibly be expected from 
this population, 26 CT scans would be needed to detect 1 
clinically meaningful unsuspected abnormality other than 
neurocysticercosis.
There was poor agreement between clinicians’ expectation 
and actual scan findings – only 16% after adjustment for chance 
agreement. The main areas of disagreement were the clinicians’ 
overestimate of the probability of granulomata and other 
specific findings, and an underestimate of the probability of a 
normal scan, present in 49% of cases but expected in only 3%. 
The falsely high expectation of abnormal findings (regardless 
of their potential impact on clinical management) is a potential 
barrier to the successful implementation of guidelines for more 
rational use of CT scans in this context.
An incidental finding of concern in this study is the large 
proportion of patients lost to follow-up. One-third of children 
for whom outpatient CT appointments were made did not 
attend for the scan. If CT scans are performed, systems must be 
in place to ensure maximal follow-up. Routine CT scanning for 
partial seizure may in itself contribute to the drop-out rate by 
adding to pressure on existing services and extending waiting 
times for the procedure.
Table II. Findings on CT scan 
N (%) 95%CI
Reported as normal 32 (34) 24 - 44%
Granuloma 45 (47)
  Single 26 (27) 37 - 58%
  Single with calcification 3 (3)
  Multiple 4 (4)
  Multiple with calcification 11 (17)
  Calcification only 1 (1)
Other 17 (18) 11 - 27%
  Incidental findings reported as not           
clinically significant or ignored by 
clinicians* 5 (5)
  Findings of uncertain significance,                  
discharged after follow-up* 4 (4)
  Specific 8 (8)
No report† 1 (1)
  Total 95
*Categorised as normal in subsequent analyses.
†Excluded from subsequent analyses.
Table IV. Agreement between clinically expected and 
actual CT findings (N)
         CT findings
Clinical




2 0 0 2
21 26 2 49
10 4 3 17
  Total 33 30 5 68
Table III. Specific findings on CT scan, other than 
granuloma
N Clinical details




3 Diagnosis clinically suspected in 
all 3 cases
Mass lesion 1 Final diagnosis tuberculous 
meningitis with tuberculoma. 
Diagnostic work-up for 






1 Clinical diagnosis before CT scan
Fracture through 
ethmoid sinus
1 Fracture visible only on special CT 




1 Previous CT scan for macrocephaly
  Total 8
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The strengths of this study include prospective enrolment 
that enabled more accurate collection of clinical data. The 
sample also included a meaningful spectrum of patients from 
a specified clinical setting. Retrospective folder review to 
measure subsequent management was unavoidable if clinical 
management was not to be interfered with. A weakness of the 
study is that children were enrolled and examined by a large 
number of clinicians involved in their routine care. This may 
have detrimentally affected the quality of clinical data and 
resulted in some missing data.
Although clinicians’ expectations were a very poor predictor 
of CT findings, the CT findings had virtually no impact on 
diagnosis, except in the common case of granuloma. The 
impact of a CT finding of neurocycticercosis depends on the 
effectiveness of treatment for neurocysticercosis. If treatment is 
ineffective, the CT scan appears to have little impact on clinical 
management, and appears unnecessary in the absence of the 
clinical suspicion of a specific finding other than granuloma. 
If treatment with albendazole is effective, the blanket use of 
albendazole in all patients presenting with partial seizures may 
result in fewer harmful effects than incurred with routine CT 
scanning (e.g. radiation dose, use of scarce resources, anxiety 
due to inconsequential incidental findings). Assuming that 
a recent imprecise estimate of the effect of albendazole on 
reducing the number of children with seizures in the first 6 
months is correct (odds ratio 0.30, 95% CI: 0.1 - 0.9),14 i.e. that 
albendazole reduces the risk of subsequent seizures from 33% 
to 13%, routine CT scanning would require 11 scans and 5 
courses of albendazole  in our setting to prevent 1 additional 
child from having seizures, compared with no CT scans and 11 
courses of albendazole with blanket use of albendazole. 
On the basis of our findings, we are restricting the use of 
CT scanning in children over the age of 2 years who present 
to the hospital with a first focal seizure and no neurological 
history and no physical signs that cannot be explained by the 
seizure itself. Investigations are limited to a chest radiograph 
and tuberculin skin test. Management includes a single dose of 
albendazole for treatment of possible intestinal tapeworm.
The applicability of the findings of this study to other 
settings depends on the prevalence of the underlying 
pathologies. The findings appear to be broadly applicable 
to settings with a high prevalence of neurocysticercosis and 
tuberculous meningitis. Health system issues such as loss to 
follow-up may occur elsewhere, suggesting that local audit 
may be necessary.
In summary, routine CT scan for children presenting 
with a first partial seizure in an area with a high prevalence 
of neurocysticercosis failed to identify findings other 
than neurocysticercosis that meaningfully altered clinical 
management. If treatment of neurocysticercosis with 
albendazole is judged to be worthwhile, the benefits of routine 
screening to identify patients with granulomata would depend 
on the prevalence of neurocysticercosis, and the trade-off 
between the benefits of albendazole and the harmful effects of 
CT scans and/or albendazole.
Funding for the study was received from the University of 
Cape Town.
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‘Small steps and big leaps’1
The process of planning and implementation of the 2010 
health plan of the Provincial Government of the Western 
Cape brought about changes in the delivery of health care 
to children. These changes emanated from a need for a more 
equitable, efficient, affordable and integrated health care 
system. To achieve these goals, a pragmatic evolution of care 
for a service delivery platform was adopted by the provincial 
and municipal health authorities. This approach resulted in the 
introduction of municipality-based health care centres.  
A network of municipality primary health care clinics 
(PHCs) functions as the first level where patients gain entry 
into the health system. These centres are situated in the 
community.  Within this new dispensation, nurse practitioners 
would primarily be responsible for managing childhood 
ailments. Should more advanced diagnosis or treatment be 
required, patients would be referred to community health 
centres (CHCs), or secondary level or tertiary health facilities. 
The referral system is depicted in Fig. 1.
While the Provincial Health Department had previously 
been directly responsible for providing health services, it 
now assumes the role of providing guidelines, co-ordination, 
funding, monitoring and supporting the PHCs, which have 
become the primary providers.
A quantum shift therefore occurred in the delivery of health 
care to children from a provincially based hospital system 
to a municipally based PHC system. To contribute towards 
enabling this process, the Department of Paediatric Surgery at 
Red Cross War Memorial Children’s Hospital (a tertiary referral 
centre) decided to establish a paediatric surgical day clinic at a 
local community health centre during 2001. The health centre 
is 1 of 9 CHC facilities that provide health services to the local 
community with a drainage population of approximately 
300 000 inhabitants.
This site was chosen because 11% of children with surgical 
conditions seen at the tertiary hospital originated from 
this community. The clinic was established after extensive 
negotiations with the health authorities and the local 
communities. A specialist paediatric surgeon conducted a 
weekly 3-hour clinic. Children were referred from five PHCs or 
seen de novo. A dedicated nurse was allocated to the clinic. 
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Objectives. The objective was to evaluate the role of a paediatric 
surgical consultant at a primary health care facility.
Design. Descriptive and prospective.
Setting. In the process of planning and implementation of the 
2010 health plan of the Provincial Government of the Western 
Cape, a shift occurred in the delivery of health care to children 
from a provincially based hospital system to a municipally 
based primary health care system. To contribute towards 
enabling this process, the Department of Paediatric Surgery 
at Red Cross War Memorial Children’s Hospital established 
a paediatric surgical day clinic at a local community health 
centre during 2001. 
Subjects. Information was obtained from patient data sheets 
containing details of consultations at the sub-specialist surgical 
clinic at Michael Mapongwana Community Health Centre. 
Results. Over a 58-month period 1 171 children were seen, of 
whom 655 were male and 427 female. Their ages ranged from 
0 to 19 years, the largest group being under 1 year. Eighty 
per cent of patients were accompanied by their mothers. The 
correct diagnosis was established by the nurse practitioners 
in 71%. General paediatric surgical conditions predominated, 
followed by medical, dermatological, orthopaedic, trauma, 
otolaryngo-pharyngology, infectious diseases, ophthalmology, 
urology, neurosurgery, malignancy and maxillofacial 
conditions. The details are set out in the report. In total 597 
patients were referred directly to an appropriate care facility 
and 574 patients could be managed entirely at the clinic level.  
Conclusions. This study demonstrated the significant public 
health problem of paediatric surgical disease. It emphasised 
the preventative and cost-effective role of a surgical clinic at 
primary health care level. The clinic allowed for timely surgical 
intervention in 65% of surgical cases, thereby decreasing 
inappropriate tertiary referrals. We believe that bringing 
specialists into the community can only strengthen the 2010 
health care plan. 
S Afr Med J 2006; 96: 945-949.




The objective of this descriptive and prospective study was to 
evaluate the role of a paediatric surgical consultant at a CHC. 
The goals were to review the demographics, disease profiles, 
referral patterns and the prevalence and magnitude of surgical 
conditions in order to better understand the surgical needs of 
the community. In addition, the quality of care provided by 
the municipal health services, the diagnostic and therapeutic 
roles that nurse practitioners play in this setting, the benefits 
and drawbacks of having a sub-specialty service at community 
level in a low-resourced and low-income environment and the 
outcome following consultation were also assessed. 
Information was obtained from the patient data sheets 
for the surgical clinic at Michael Mapongwana Community 
Health Centre. The information reported reflects those patients 
attending the sub-specialist paediatric surgery clinic from 
March 2001 to December 2005.  When the opportunity arose, 
the time at the clinic was used to educate medical students 




One thousand one hundred and seventy-one paediatric 
patients were assessed and managed over the 58-month period. 
Patient numbers generally increased as the clinic became well 
known, from 160 in 2001 to 345 in 2005. Ages ranged from 0 
to 19 years, the largest group being under 1 year of age. There 
were 655 males and 427 females (Fig. 2). The gender of 89 
patients was not documented.                                                         
Accompanying person
The accompanying guardian was noted on 469 patient data 
sheets. Mothers accompanied the patients in 375 cases (80%), 
and fathers in 35 cases (7%). Six children presented with no 
escort.
Diagnostic accuracy of nurse practitioners’ referral 
letters
A referral diagnosis made by the nurse practitioner from the 
referring municipal clinic was recorded in 357 cases. The 
correct diagnosis was established in 255 children (71%) and the 
diagnosis was incorrect in 102 (29%).
Medical sub-specialties
Fig. 3 represents an analysis by medical specialty of the total 
number of children seen at the clinic. As could be expected, 
general paediatric surgical conditions predominated, followed 
Fig. 1.  Referral pattern for patients under the 2010 health care plan.
Fig. 2. Age and gender distribution of patients.
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by medical, dermatological, orthopaedic, trauma otolaryngo-
pharyngology, infectious diseases, ophthalmology, urology, 
neurosurgery, malignancy and maxillofacial conditions. 
General surgery
Four hundred and thirty-one surgical patients were seen and 
a total of 451 diagnoses made. The prevalence and analysis of 
surgical disease profiles are depicted in Table I.  Minor surgical 
conditions were more prevalent and most required elective 
surgical intervention.  Acute appendicitis was diagnosed 
in 2 children, and 2 cases of malignancy, both advanced, 
were incorrectly diagnosed initially at PHC level. Four other 
children had lumps that were subsequently diagnosed as 
malignant. Management of surgical conditions involved 285 
patients being referred to selected tertiary level facilities. In 
104 children, management consisted of observation, advice 
and review. Antibiotics, analgesia and other medications were 
given to 36 children. The balance received dressings for burn 
wounds or septic wounds or had abscesses aspirated.
Medical conditions
A total of 140 medical patients were observed with a total of 
164 diagnoses. Although there was a clinical suspicion of HIV 
infection in many patients, only 22 patients were tested and 
documented as HIV-positive. Developmental delay, respiratory 
diseases and HIV accounted for 71% of the diseases. Sixty-six 
patients were treated on site with medication and antibiotics. 
Fifty-one required referral. Further investigations and social 
grant applications were required in 25. 
Dermatology
Dermatological conditions (in 144 children) were among 
the most common conditions encountered. These consisted 
of primary skin disorders and infections, and molluscum 
contagiosum in 93%. One hundred and six patients were 
managed at the clinic either by prescription of medication or 
local procedures and management, while 38 were referred 
to a dermatology department for diagnostic and therapeutic 
reasons. 
Orthopaedics
During the 58 months 120 orthopaedic patients were seen and 
managed. Their diagnoses ranged from congenital skeletal 
abnormalities to fractures and bone and joint infections. These 
diagnoses accounted for 83.3% of orthopaedic conditions. 
Seventy-two patients required referral to a tertiary care 
institution, while 48 patients could be dealt with locally with 
splinting, prescription of medication and minor procedures.
Other conditions
Nine children were seen after a non-accidental injury (NAI); 
2 of these had been assaulted and sustained fractures, while 
7 had been sexually assaulted. These children were managed 
according to the NAI protocol of the Western Cape.
Other sub-specialty patients were also seen. Ninety-one 
patients had problems of an ENT nature, mostly otitis media, 
foreign bodies in the ear or nose, and parotitis (related to 
HIV). Ophthalmological cases numbered 65 – meibomian 
cysts, strabismus, visual impairment, conjunctivitis and 
molluscum contagiosum being the most common diagnoses. 
Infectious diseases were documented in 76 patients. These 
included the usual childhood viral infections of mumps, 
measles, chickenpox, and most commonly tuberculosis. Central 
nervous system conditions (hydrocephalus and post-traumatic 
headaches) were encountered in 13 patients. 
Acute trauma was diagnosed in 45 patients. This included 
a spectrum of injuries such as lacerations, contusions and 
fractures. Nineteen were referred, the others being treated at 
the local level with dressings, splinting or sutures. Forty-two 
patients presented with a history of burns, either acute or with 
chronic contractures. Fourteen of these were referred to a burn 
unit, one as an emergency. The others were managed locally 
with satisfactory outcome. 
Excluding undescended testes and phimosis, 41 patients 
with a problem of a urological nature were encountered. The 
Fig. 3. Patient numbers in each specialty.
Table I. General surgical diagnoses
Diagnosis     Number
Inguino-scrotal pathology    157
Abscess/cellulitis/infection     92
Mass/cyst      53
Umbilical hernia/granuloma     34
Minor surgical conditions     28
Peri-anal conditions      21
Lymphadenopathy      17
Phimosis/paraphimosis/balanitis    14
Oesophageal atresia/stricture/dysphagia     9
Abdominal pain/constipation       9
Appendicitis        2
Malignancy – sarcoma/leukaemia/lipoma     6
Normal          9
  Total       451
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most common diagnoses were congenital mega-prepuce, 
hypospadias and incontinence. Because of the nature of these 
problems, 29 patients were referred.
Overall management
Table II reflects the management of the group as a whole. In 
total 597 (51%) were referred directly to an appropriate care 
facility and department and 574 (49%) could be managed at the 
clinic level. Management included prescription of medication, 
dressings, advice and reassurance, and application for social 
care grants.  
The surgeon was involved in the resuscitation of 2 children 
during this period. One had inhaled paraffin and the other 
was in shock as a result of gastroenteritis. Emergency 
ambulance transfer was not immediately available and they 
were transported directly to the tertiary unit in the surgeon’s 
car. One neonate at the adjoining midwife obstetric unit was 
certified dead at birth.
There were occasional adult consultations for trauma, 
abdominal pain, surgical infections, diabetes, TB, haemoptysis 
and vascular abnormalities. The statistics for these conditions 
were not included in the audit.
Discussion
Primary health care is defined as provision of first contact 
care; it is aimed at providing continuity, co-ordination and 
comprehensiveness. For this service to function optimally, it 
has to be multidimensional and requires a pathway for referral 
for diagnostic and management options when required. This 
survey has highlighted many of these aspects.
As part of the 2010 health plan of the Western Cape, an 
impressive network of municipally based primary health 
care facilities was developed where nurse practitioners were 
primarily responsible for preventive and primary curative 
care. However, within this new dispensation the provision 
of basic paediatric surgical care at primary and secondary 
levels was deficient, hence the decision to establish a surgical 
platform at this level. This novel service was introduced as 
a complementary service to the existing municipality health 
clinics.
Paediatric surgical disease is a significant public health 
problem. In an attempt to determine the surgical needs of 
children in Africa, it was estimated that 543/10 000 children, 
aged 0 - 14 years will require surgical care on an annual 
basis. Furthermore, a total of 46% of children presenting with 
surgical problems required surgical procedures, 68% of which 
were classified as minor. The estimated accumulated risk of 
developing surgical conditions was 85% by the age of 15 years.2
Traditionally surgery has been seen as an expensive, 
high-tech service and not considered part of a primary 
public health model. Primary health care policies, although 
excellent for child health in general terms, did not adequately 
address or reflect the surgical needs of children in the PHC 
system. (Powell D, Van der Merwe B, De War R. Survey of 
Child Health Services in the Western Cape Province, May 
2003 – unpublished data available at the Institute of Child 
Health Library, Red Cross Hospital (printed copy as well as 
CD)).There is considerable uncertainty about a national and 
provincial plan for paediatric surgery, the lack of surgical 
facilities for children at primary health care level, the lack of 
anaesthetic facilities for children at a secondary level and the 
future role of specialists and sub-specialist paediatric surgical 
services at primary, secondary and tertiary level. The issue is 
not whether selected children can receive surgical care, but 
whether children have access to appropriate services.3
As primary care facilities developed, a progressively greater 
number of children were identified with surgical conditions 
and a concomitant need for an increase in primary surgical 
care or referral for diagnosis and treatment developed. The 
wide spectrum of diseases and conditions documented in this 
series is a reflection of the surgical needs of the community, 
and can also serve as a barometer of surgical needs in any 
stable regional community. Although this clinic was primarily 
established as a surgical service, 30% of the patients seen had 
diagnoses of a ‘medical’ nature. This possibly emphasises the 
need for such clinics to be established in other disciplines.
In our tertiary institution the outpatient load is 
disproportionately high for specialist attention. A large 
percentage of patients could be dealt with at non-specialist 
level, but are at present referred because of a lack of specialised 
services or knowledge of surgical conditions within community 
facilities. In this series 49% of patients were treated at the 
community level with no need for further referral. Had this 
clinic not been in operation, these patients would have been 
referred to already congested secondary and tertiary services. 
The proximity of a surgical specialist clinic to the primary 
health care clinics thus allows for easy referral of patients to the 
tertiary institution and lessens the financial burden on patients.
On the other hand, 51% of patients were referred directly to 
the appropriate surgical clinic or booked directly for surgical 
intervention, negating a preoperative outpatient visit. Patients 
thus receive streamlined service, with less waiting, fewer 
Table II. Management summary of total cases
Management    Number
Referred/admitted       597
Observed/followed up      142
Antibiotics/medications/analgesia     234
Advised/X-rays       145
Dressings          32
Social grant         12
Plaster of Paris            9
  Total       1 171
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points of contact within the system because of direct referral 
from a primary to a tertiary institution, less time off work and 
school, and reduced transport costs while the tertiary system is 
less flooded with outpatient visits. 
A substantial number of children were seen with conditions 
necessitating early referral, including sick, dehydrated children 
and those with appendicitis, fractures, burns, diarrhoea and 
paraffin inhalation. Ambulance services were not always 
available as they were overburdened, hence the immediate 
transfer of 27 patients by means of private transport.
We were pleasantly surprised by the diagnostic and 
therapeutic skills of the PHC nurse practitioners. However, in 
29% of cases their initial diagnosis or treatment programmes 
were incorrect. Inadequate history taking, inability to elicit and 
interpret clinical signs and symptoms and unfamiliarity with 
surgical conditions were contributing factors. The extended 
role of nurse practitioners in this area of primary care must be 
encouraged.4 Surgeons must be involved with their training 
and supervision through the establishment of a continuing 
medical education programme, incorporating eight surgical 
sub-specialties.
The medical and pharmaceutical infrastructure within 
the CHC were adequate to meet the local demands. A 
knowledgeable clinic nurse is essential, not only for organising 
the clinic, but also for translation purposes, history taking, 
and explanation of the condition and outcome. The clinic also 
offers an ideal opportunity to engage in a holistic health care 
approach, i.e. immunisation, physical growth assessment, 
developmental needs and psychosocial issues in the family.  
Mothers carry a heavy burden in caring for their children. Of 
the cases where details of the accompanying individual were 
recorded, 80% of the children were brought to the clinic by 
their mothers. They often have to take a whole day off work 
and pay large transport fares to get to a tertiary centre. Having 
a community-based clinic allows the mothers to go to work for 
the second half of the day, thus decreasing the time off work 
– vital in this impoverished community where no work often 
means no pay. 
The PHC system for children will not function well without 
an efficient referral and communication system. Problems 
encountered were difficulties in contacting the appropriate 
referral centres, long waiting lists for tertiary clinics, seeking 
the father’s consent for surgical procedures and significant 
financial constraints. Another restricting factor has been the 
lack of communication from the tertiary centre once a patient 
was referred. Over the duration of the study, the CHC only 
received 13 (2.3%) letters of acknowledgement and outcome 
from the tertiary services. We regard these replies as vital 
feedback to the primary nurse practitioners, to further their 
understanding and diagnostic ability. 
The success of this clinic suggests that there is a role for sub-
speciality services at PHC level. Clinics of this nature could 
be run on a weekly or monthly basis. The argument that sub-
specialists are unable to conduct a general surgical or medical 
clinic at PHC level is not valid. This is substantiated by our 
findings. We believe that the presence of sub-specialists will 
make a definitive difference to both primary health care and 
tertiary care clinics.
Conclusions
This study demonstrated the significant public health 
problem of paediatric surgical diseases. It also emphasised the 
preventive and cost-effective role of a surgical clinic at primary 
health care level, which strengthens the 2010 health care plan.
A specialist consulting at a primary health centre allows 
more children to be seen at an appropriate level. This allowed 
for timely and cost-effective medical intervention in the 
majority of children, thereby decreasing inappropriate hospital 
admissions, outpatient visits and reducing the overall financial 
burden. Other benefits include opportunities for continuing 
medical education for medical students, community service 
doctors and nurses, and facilitation of social grant applications. 
The authors wish to thank the staff at the Michael Mapongwana 
Community Health Centre in Khayelitsha for their co-operation, the 
referring primary health care nurses and Linda Mayekise who has 
rendered such excellent service over the years.
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Burkitt’s lymphoma (BL) is the third most common solid 
tumour occurring in children in Africa, being exceeded only 
by brain tumours and Wilms' tumour. This is due to the high 
incidence of endemic BL (estimated at 40 - 100 per million 
per year in children under 15)1 in the ‘lymphoma belt’, 
an area from 10o north to 10o south of the equator, which 
corresponds roughly with the malaria belt. The ability of 
the Epstein-Barr virus (EBV) to transform lymphocytes by 
inducing the translocations typically found in BL appears to 
be augmented by malarial parasitaemia. These translocations 
involve the c-Myc oncogene on chromosome 8 and one of the 
immunoglobulin heavy or light chain loci on chromosomes 2, 
14 and 22.
The endemic form found in these areas is characterised by 
a jaw mass (58%), with or without abdominal disease (58%). 
Bone marrow involvement is rare (7%) but central nervous 
system involvement is more common (19%). The sporadic form 
found throughout the Western world typically presents as an 
abdominal mass (88%). Bone marrow involvement is more 
common than in the endemic form (21%) while jaw masses 
(14%) and central nervous system involvement (11%) are less 
common.2 In South Africa most cases fall into the sporadic 
group. 
This review examines the evolution in treatment for BL at 
Red Cross War Memorial Children’s Hospital (RCCH) between 
1984 and 2004. With the use of protocol 1 (P1) and aggressive 
surgery during the 1980s, excellent results were being achieved 
for patients with extensive localised disease. This was however 
at the cost of considerable surgical morbidity, and the outcomes 
of patients with bone marrow and central nervous system 
involvement remained dismal. A more intensive regimen, 
protocol 2 (P2), was introduced during the late 1980s, first for 
those with disseminated disease, and then for localised disease. 
At the same time a consensus was emerging internationally 
that with more intensive chemotherapy, debulking of large 
abdominal tumours was no longer necessary.3 In addition, 
relook surgery to assess disease response after induction 
chemotherapy could be reserved for patients where residual 
disease was suspected.
We undertook this review of patients treated for BL at 
RCCH in order to establish whether our patients with 
disseminated disease have a superior survival with P2 and 
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Background.  Treatment for Burkitt’s lymphoma at Red Cross 
Children’s Hospital has evolved from the use of aggressive 
surgery and less intensive chemotherapy to a conservative 
surgical approach with more intensive chemotherapy.
Methods. The study was a retrospective folder review of 
patients diagnosed with Burkitt’s lymphoma at RCCH between 
1984 and 2004.
Results. Ninety-two children were treated for Burkitt’s 
lymphoma at RCCH between 1984 and 2004. There were 10 
patients with group A or fully resected disease, 52 with group 
B or extensive localised disease, and 30 with dissemination 
to the bone marrow and/or central nervous system or group 
C disease. Protocol 1 (less intensive chemotherapy based on 
the COMP regimen) was used from 1984, with protocol 2 
(more intensive chemotherapy based on the LMB regimen) 
introduced in 1988 for group C disease, 1991 for group B 
disease and 1996 for group A disease. Overall 5-year survival 
increased from 20% with protocol 1 to 66% with protocol 2 for 
group C disease, and from 76.5% with protocol 1 to 88.2% with 
protocol 2 for group B disease. There were more admissions 
for neutropenic fever in patients on protocol 2 and more 
episodes of mucositis, and these patients required more red cell 
and platelet transfusions. With a more conservative surgical 
approach, biopsy largely replaced attempts to partially resect 
the tumour at primary surgery, and there was a consequent 
decline in surgical complications.
Conclusions. Intensive chemotherapy with protocol 2 has 
resulted in improved survival for group C and group B 
patients, but with more morbidity.  Protocol 1, which is less 
intensive with less morbidity, remains a viable strategy for 
group A and group B disease in resource-poor settings.
S Afr Med J 2006; 96: 950-954.
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whether the outcome for extensive localised disease improved 
despite the increased toxicity associated with more intensive 
chemotherapy. 
Methods
The study was a retrospective folder review of patients 
diagnosed with BL at RCCH between 1984 and 2004. Patients 
were identified from the Oncology Registry of the RCCH 
Haematology-Oncology Service. Data on each patient were 
collected from the hospital notes.  Four HIV-positive patients 
presented with BL between 2003 and 2004. These patients were 
treated with antiretroviral therapy and an alternative protocol, 
and were excluded from this study.
The diagnosis of BL was made on histological examination. 
Upon diagnosis, staging for each patient involved bilateral 
bone marrow biopsy, and examination of the cerebrospinal 
fluid (CSF). Chest X-ray and ultrasound of the abdomen were 
mandatory, and CT scans of the head, chest or abdomen were 
obtained where indicated.
During the early years of the study, tumours were partially 
or completely resected where possible. More recently this was 
gradually superseded by biopsy (via laparotomy or laparoscopy) 
for all but small localised intra-abdominal tumours. Definitive 
surgery was performed in patients presenting with intraluminal 
complications such as intussusception. When the diagnosis 
could be made from the bone marrow, or cerebrospinal, pleural 
or ascitic fluid, surgical biopsy was not performed. 
The patients were divided into groups according to the 
risk stratification devised by the French Paediatric Oncology 
Society4 (Table I).
Two chemotherapy protocols were used, P1 based on the 
COMP arm of United States Children’s Cancer Group protocol 
CCG-551,5 and P2 based on the French Paediatric Oncology 
Society protocol LMB-89 (Fig. 1).6 P2 was introduced for group 
C patients in 1988, for group B patients in 1991, and for group 
A patients in 1996.
All patients were treated with allopurinol, hyperhydration 
and urinary alkalinisation at the commencement of induction 
chemotherapy to prevent tumour lysis syndrome. Granulocyte 
colony stimulating factor at a dose of 5 µg/kg per day for 
14 days was used in an attempt to shorten the period of 
neutropenia following intensive chemotherapy in P2.
Originally, second-look laparotomy was often performed 
as part of the review of advanced abdominal disease after 
induction chemotherapy. Later, it was reserved for cases where 
there was clinical or radiological suspicion of residual disease.
Relapse-free and overall survival were estimated by the 
method of Kaplan and Meier. Survival analysis was performed 
using Statistica 6.1 (Statsoft, Inc. 1984 - 2003).
Results
Ninety-two HIV-negative patients with BL were admitted to 
RCCH between January 1988 and December 2004. There were 
64 males and 28 females, with a male/female ratio of  2.3:1. The 
patients ranged in age from 1.6 to 13.95 years, with a median 
age of 5.53 years. The two treatment cohorts had an almost 
identical demographic profile.
Seventy patients (76%) presented with symptoms related to 
abdominal disease, including pain, distension and vomiting. 
Nine patients presented with a jaw mass, and 6 with a neck 
mass. Four presented with generalised adenopathy and bone 
pain, and 3 with paresis due to paraspinal masses.
At diagnosis 77 (83.6%) were found to have abdominal 
disease. Fifty-nine had bowel involvement, including 10 with 
intussusception. Twenty patients had disease involving the 
liver and 10 had renal involvement. Thirteen patients had 
involvement of the uterus, ovary or bladder and 1 patient had 
involvement of the testes. Twenty-five patients had ascites. 
Nine patients (9.8%) had jaw masses and 12 patients had 
pleural effusions. 
Fifteen patients (16.3%) had central nervous system 
involvement at diagnosis. Three had paraspinal masses, 4 had 
central nervous system masses with cranial nerve palsies, and 
11 had blasts in the cerebrospinal fluid. Twenty-five patients 
(27.2%) had more than 25% blasts in the bone marrow. Ten of 
these patients also had central nervous system involvement. 
In all, 30 patients (32.6%) had group C disease; 15 with 
leukaemia, 5 with central nervous system involvement and 
10 with both. Ten patients (10.9%) had group A disease; 9 had 
fully resected localised abdominal lymphomas and 1 cervical 
adenopathy. The other 52 patients (56.5%), including 6 with 
less than 25% blasts in the bone marrow, had group B disease. 
There were more group C patients in the P2 cohort (40% for 
P2 v. 17% for P1), and less group A patients (5% v. 23%), due to 
the staggered introduction of this protocol. Both cohorts had a 
similar percentage of group B patients (55% v. 60%).
All group A patients had complete resection. Thirteen 
(61.9%) of the abdominal group B and C patients treated with 
P1 but only 8 (15.7%) of those treated with P2 had partial 
resection. Second-look laparotomy was performed for 10 
Table I. Risk stratification for Burkitt’s lymphoma (devised 
by the French Pediatric Oncology Society)
Group A   Complete surgical resection of stage I or 
abdominal stage II
Group B   All patients not eligible for group A or 
group C
Group C    Any tumour with CNS involvement
Any tumour with more than 25% blasts in 
the bone marrow
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(33.3%) patients treated with P1 – in 
all but 1 case as a routine procedure. 
Fourteen (22.5%) of those treated with 
P2 underwent relook laparotomy 
– all had a residual mass on clinical 
examination or imaging. In only 4 of 
these 24 cases was there histological 
evidence of lymphoma, and in all cases 
this was strongly suspected on clinical 
examination and imaging.
All group A patients on both 
protocols survived. The estimated 
5-year overall survival for group B 
patients was 76.5% with P1, and 88.2% 
with P2 (p = 0.35) (Fig. 2). There were 
5 deaths with P1, 4 from recurrent 
lymphoma and 1 in remission as a 
result of varicella encephalitis. Five 
of those treated with P2 died: 2 had 
recurrent lymphoma, 1 developed 
bowel infarction and peritonitis 
following surgery for tumour-related 
intestinal obstruction, and 2 deaths were 
treatment-related – 1 during induction 
with haemorrhagic oesophagitis, and 1 
in remission with cerebral aspergillosis.
The estimated 5-year overall survival 
for group C patients was 20.0% with 
P1, and 66.0% with P2 (p = 0.04) (Fig. 
3). All 4 deaths with P1 were the result 
of BL recurrence. Of those treated with 
P2, 6 died of recurrent disease, and 2 
deaths were treatment-related. Both of 
these occurred during induction – 1 as a 
result of Gram-negative septicaemia and 
1 due to mucormycosis.
Twenty-eight patients (30.4%) 
developed tumour lysis syndrome 
requiring some form of medical 
intervention. Three of these patients 
were treated with P1 and none required 
dialysis, whereas 25 were treated 
with P2 and 12 of them required 
either peritoneal or haemodialysis.  
All patients requiring dialysis had 
high tumour burdens with extensive 
abdominal disease (2), leukaemia (7) or 
large pleural effusions (3). 
Twelve of the 49 abdominal group 
B and C patients who had laparotomy 
with biopsy or partial resection had 
surgical complications. These included 
adhesive small-bowel obstruction (6), 
anastomotic leaks or perforations (6), 
volvulus (1) and jejunal obstruction 
(1). Of the 13 in the P1 cohort who had 
partial resection, 5 patients (38.5%) 
experienced complications – mainly 
anastomotic leaks. Two of the 8 patients 
(25%) in the P2 cohort who underwent 
partial resection suffered adhesive 
small-bowel obstruction.
There were 26 episodes of 
neutropenic fever with P1 (0.9 episodes 
per patient) compared with 192 in the 
group treated with P2 (3.1 episodes per 
patient). There were also more positive 
blood cultures in the P2 cohort (0.94 
per patient) compared with the P1 
cohort (0.27 per patient). Transfusion 
requirements were higher for the P2 
cohort. These patients required 4.1 
red cell transfusions and 4.0 platelet 
transfusions per patient compared 
with 1.4 and 0.6 respectively for those 
treated with P1. Severe mucositis was 
more frequent with P2 (1.9 episodes per 
patient) compared with P1 (0.3 episodes 
per patient).
Among group B patients treated 
with P2, 88% required at least one red 
cell transfusion and 62% at least one 
platelet transfusion. Ninety-one per 
cent of patients suffered an episode of 
febrile neutropenia, and 97% suffered 
severe mucositis. Frequency of episodes 
BURKITT LYMPHOMA PROTOCOL ONE
(based on the COMP arm of United States Children’s Cancer Group protocol CCG-551)
INDUCTION    MAINTENANCE (monthly for 6 
     cycles)
Cyclophosphamide 1 200 mg/m2 IV  Cyclophosphamide 1 000 mg/m2 IV
Prednisone 60 mg/m2 PO daily for 28 days Prednisone 60 mg/m2 PO daily for 5 days
Vincristine 2 mg/m2 IV weekly x 4   Vincristine 1.5 mg/m2 IV x 2
Methotrexate IT   Methotrexate IT
Methotrexate 300 mg/m2 IV   Methotrexate 300 mg/m2 IV
BURKITT LYMPHOMA PROTOCOL TWO
(based on the French Paediatric Oncology Society protocol LMB-89)
GROUP A 1. Cyclophosphamide 250 mg/m2 IV 12-hourly x 6  2 cycles
Vincristine 2 mg/m2 IV x 2
Prednisone 60 mg/m2 PO/day x 5 days
Doxorubicin 30 mg/m2 IV daily x 2
GROUP B 1. Cyclophosphamide 300 mg/m2 IV  1 - 2 cycles
Vincristine 1 mg/m2 IV
Methotrexate + Hydrocortisone IT
Prednisone 60 mg/m2 PO daily for 7 days
2. Vincristine 2 mg/m2 IV  2 cycles
Methotrexate 3 g/m2 IV over 3 hours
Prednisone 60 mg/m2 PO daily for 5 days
Cyclophosphamide 250 mg/m2 IV 12-hourly x 6
Doxorubicin 30 mg/m2 IV daily x 2
Methotrexate + Hydrocortisone IT x 2
3. Methotrexate 3 g/m2 IV over 3 hours  2 cycles
Cytarabine 100 mg/m2 IV daily x 5
Methotrexate/Cytarabine + Hydrocortisone IT x 2
4. Repeat 2 … but …  1 cycle
Cyclophosphamide 500 mg/m2 IV daily x 2
Methotrexate + Hydrocortisone IT x 1
GROUP C 1. As for Group B … but …   1 - 2 cycles
Methotrexate + Hydrocortisone + Cytarabine IT x 3   
2. As for Group B … but …  2 cycles
Methotrexate 8 g/m2 IV over 4 hours
Methotrexate + Hydrocortisone + Cytarabine IT x 3
Cyclophosphamide 500 mg/m2 IV 12 hourly x 6 for 2nd cycle
3. Cytarabine 50 mg/m2 IV x 5  2 cycles
Cytarabine 2000 mg/m2 IV x 4
Etoposide 100 mg/m2 IV x 5 
Methotrexate + Hydrocortisone IT x 1 for CNS disease
Methotrexate 8 g/m2 IV and triple IT therapy between cycles for CNS disease
4. Repeat 2 … but …  1 cycle
Cyclophosphamide 500 mg/m2 IV daily x 2
Methotrexate + Hydrocortisone + Cytarabine IT x 1
Fig. 1. Protocols used for Burkitt's lymphoma at RCCH, 1984 - 2004.
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of neutropenic fever and severe mucositis, as well as red cell 
and platelet requirements, were particularly high for group C 
patients treated with P2.
Discussion
BL was first described by Dennis Burkitt in Uganda in 1958 as 
a ‘sarcoma involving the jaw in African children’.7 He observed 
its dramatic response to chemotherapy, demonstrating a 
number of long-term remissions with one or two doses of 
cyclophosphamide.8 Further evaluation showed that this 
endemic variant was clinically related, and histologically 
identical, to the abdominal form9 that constitutes the sporadic 
variant. Initially treatment consisted of surgical cytoreduction 
where possible and chemotherapy.10
The subsequent evolution of BL treatment has seen the use 
of increasingly intensive chemotherapy and a reduction in the 
role of surgery. Early work demonstrated increased survival 
where complete resection could be achieved,11 and advocated 
an aggressive surgical approach to BL.12 As the efficacy of 
chemotherapy regimens improved, it became obvious that 
aggressive attempts at surgical cytoreduction delayed the 
administration of chemotherapy, and were associated with an 
increase in complications requiring surgical intervention.13,14
Debulking surgery to reduce tumour bulk no longer appears 
to be necessary. Surgery is now only required for diagnostic 
purposes, or in the event of surgical complications of the 
lymphoma such as intestinal obstruction. 
While regimens such as COMP,15 on which P1 was based, 
proved very effective for patients with localised disease, cure 
for those with dissemination to the bone marrow or central 
nervous system remained elusive. Successive studies by groups 
in France16,17 and the USA18 showed that high cure rates could 
be obtained with more intensive chemotherapy. The French 
reported a 5-year overall survival of 100% for group A, 94% for 
group B and 85% for group C.6  
Our patients fitted the profile of the sporadic type of BL. 
Abdominal disease predominated (83.6%) with few jaw masses 
(9.8%), and bone marrow involvement (27.2%) was more 
common than central nervous system involvement (16.3%). 
As in all other series males predominated but the median age 
(5.53 years) is younger than that reported in the French study 
(8 years). This is presumably the result of almost universal 
exposure to EBV at a young age. The high rate of dissemination 
to the bone marrow and/or central nervous system (32.6%) 
illustrates the ongoing problem of late diagnosis of childhood 
malignancy in South Africa. There were only 21.9% group C 
patients in the French study.6
The introduction of P2 improved the estimated 5-year overall 
survival for group C patients from 20.0% for those treated with 
P1 to 66.0% for those treated with P2 (p = 0.04). There is a trend 
for improved survival among group B patients with an increase 
in the estimated 5-year overall survival from 76.5% with P1 to 
88.2% with P2 (p = 0.35). The group B results are comparable to 
the 94% reported by the French, but the group C results are still 
disappointing compared with the 85% reported in the French 
study.6
Side-effects of chemotherapy have increased with the 
introduction of P2. Group B and C patients had more episodes 
of neutropenic fever and severe mucositis, and higher blood 
product requirements. There were 4 treatment-related deaths 
with P2 – 2 in group B and 2 in group C – and there was a high 
rate of tumour lysis requiring dialysis.
Our patients appear to have experienced more side-effects 
than those treated in the French study. Treatment-related 
mortality was higher among both our group B patients (5.9% 
v. 0.8%) and our group C patients (8% v. 4.1%). Our group B 
patients required more red cell transfusions (88% v. 58%) and 
platelet transfusions (62% v. 17%), and suffered more episodes 
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Fig. 3. Estimated overall 5-year survival for group C Burkitt’s lymphoma, 
1984 - 2004.
Estimated Overall 5-year Survival
Group B Burkitt Lymphoma 1984 - 2004







































Fig. 2. Estimated overall 5-year survival for group B Burkitt’s lymphoma, 
1984 - 2004.
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of febrile neutropenia (91% v. 82%) and severe mucositis (97% 
v. 38%).6
Partial tumour resection among group B and C patients 
declined from 61.9% with P1 to 15.7% with P2. At the same 
time the surgical complication rate following complete or 
partial resection declined from 38.5% with P1 (more than half 
of them anastomotic leaks) to 25% with P2 (both adhesive 
small-bowel obstruction). Second-look laparotomy rates also 
decreased from 33.3% on P1 to 22.5% on P2. Laparoscopy has 
been increasingly used for diagnosis in place of laparotomy, 
with the aim of minimising adhesions and consequent bowel 
obstructions.
In conclusion, the introduction of more intensive 
chemotherapy for the treatment of BL at RCCH has resulted in 
a marked increase in survival for patients with disseminated 
disease. Survival has improved more modestly for extensive 
localised disease, but this has been accompanied by increased 
morbidity, which appears to exceed that reported in the 
French study. A more conservative surgical approach to BL has 
decreased the surgical complication rate.
In our unit patients with extensive localised disease treated 
with P1 attained a 76.5% estimated 5-year overall survival. This 
compares favourably to the 62% failure-free survival reported 
in the original USA study,4 and the 77.4% event-free survival 
reported in Lebanon for locally advanced disease.19 Only one 
death in our P1 cohort was treatment-related, and toxicity was 
mainly limited to neutropenic fever and anaemia requiring red 
cell transfusion.
While regimens similar to P2 (also based on the French 
LMB protocol) are used in other South African centres,20 less 
intensive regimens such as P1 are still used in the developing 
world. These regimens with their low side-effect profile and 
minimal transfusion requirements are ideal for African centres 
with limited resources, and are recommended for children with 
group B BL in these settings.
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Renal transplantation has undoubtedly become the therapy of 
choice for children with end-stage renal failure,1 allowing them 
to return to a fairly normal way of life at home and to return 
to school. However paediatric renal transplant programmes 
have many challenges especially in a developing country. 
Optimising renal allograft survival is important because of 
limited resources to treat irreversible renal failure.2,3 Paediatric
numbers remain low compared with adult programmes 
and contribute approximately 2% of any national dialysis 
programme.4
Patients and methods
A retrospective folder review was done of all patients < 16 
years old who received renal transplants at Red Cross War 
Memorial Children’s and Groote Schuur Hospitals’ combined 
Transplant Unit from August 1968 to April 2006. The first 
paediatric transplant was performed in August 1968 and to 
date 149 renal transplants have been performed in 132 patients. 
Eighty-nine (60%) transplants have been performed in the 
last 10 years (1995 - 2005). The number of paediatric renal 
transplants per year is shown in Fig. 1.
Fourteen children received 2 grafts, 2 children 3 grafts and 1 
child 4 grafts (2 at another centre). Gender distribution was 67 
males and 65 females, who ranged in weight from 8 kg to 63 
kg. Thirty-five (24%) received grafts from living related donors 
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Introduction. Renal transplantation is the therapy of choice 
for children with end-stage renal failure. There are many 
challenges associated with a paediatric programme in a 
developing country where organs are limited.
Methods. A retrospective review was undertaken of 149 
paediatric renal transplants performed between 1968 and 2006 
with specific emphasis on transplants performed in the last 10 
years. Survival of patients and grafts was analysed and specific 
problems related to drugs and infections were reviewed.
Results. On review of the total programme, 60% of the 
transplants have been performed in the last 10 years, with 
satisfactory overall patient and graft survival for the first 8 
years post transplant. At this point, transfer to adult units with 
non-compliance becomes a significant problem. 
Rejection is less of a problem than previously but 
infection is now a bigger issue – specifically tuberculosis 
(TB), cytomegalovirus (CMV) and Epstein-Barr virus (EBV) 
infections with related complications. A wide variety of drugs 
are available for tailoring immunosuppression to minimise 
side-effects.
Conclusion. It is possible to have a successful paediatric 
transplant programme in a developing country. However, 
to improve long-term outcomes certain issues need to be 
addressed, including reduction of nephrotoxic drugs and 
cardiovascular risk factors and providing successful adolescent 
to adult unit transition.
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Fig. 1. Number of paediatric renal transplants by year.
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and 114 (76%) were cadaveric transplants. Age at the time of 
transplant is shown in Fig. 2.
Four combined liver-kidney transplants were performed, 3 
for primary hyperoxaluria and 1 for polycystic kidney disease 
with hepatic fibrosis. These patients have currently survived 
between 2 and 6 years post transplant and all have adequate 
graft function. Causes of renal failure are shown in Table I.
HLA matching is not ideal and often 5 or more mismatches are 
present. 
Our first-line immunosuppression remains cyclosporin, 
azathioprine and prednisone, but we do have the ability to 
tailor immunosuppression to suit individual patients. Other 
drugs used include tacrolimus (Prograf/FK), mycophenolate 
mofetil (MMF) and sirolimus (Rapamycin). We use steroids 
and wean to 2.5 mg on alternate days (or 0.05 mg/kg/day) as 
the lowest dose – no complete steroid withdrawal or steroid 
avoidance is practised.
Induction agents (basiliximab, daclizumab) in the form 
of interleukin (IL) 2 receptor blockers have been used and, 
for cost containment, we have used daclizumab for smaller 
children (9 cases) and basiliximab for bigger children (7 cases). 
Acute rejection has been biopsy proven and then treated 
with ‘pulsed’ intravenous methylprednisolone in dosing of 10 
mg/kg/dose for 3 - 4 doses followed by increased oral steroids.
Complications resulting in graft loss have included rejection 
(1 graft lost due to hyperacute rejection) and surgical problems 
(2 cases of vascular thrombosis), with infections remaining the 
biggest problem.
Tuberculosis (TB) is endemic in our region (638 cases/
100 000 population) and often presents late. During transplant 
workup, every patient is screened for TB (history of contact or 
previous TB, skin testing, gastric washings for bacilli and chest 
X-ray) and prophylaxis is not routinely used. Epstein-Barr 
virus (EBV) and cytomegalovirus (CMV) infections also remain 
a major issue. Identification of CMV and EBV status of both 
donor and recipient is performed and where necessary 2 weeks 
of intravenous ganciclovir prophylaxis is administered.  
Vaccinations that have been added to our routine 
immunisations schedule (polio, haemophilus b, diphtheria, 
pertussis, tetanus, hepatitis B) include hepatitis A and varicella 
zoster. Adequate immunisation prior to transplant is important 
with continued surveillance of non-live vaccines on a regular 
basis post transplantation.  
Adolescent issues include our current adolescent cut-off 
age of 13 years after which the patients are transferred to an 
adult renal service in large referral hospital. This part of the 
programme produces most of the compliance issues with 
recent action implemented including preceding psychosocial 
input and transition at older age (Fig. 3).
Statistics. Kaplan Meier plots were used for calculating 
patient and graft survival.
Results
Survival figures 
In the last 10 years we have performed 89 paediatric renal 
transplants; 68 patients are being followed up locally. Notably 
we are following up 38 patients who are ‘over age’ according to 
our cut-off of 13 years (see Fig. 3).
Graft survival for the overall programme is 72% at 1 year 










Fig. 2. Age at time of transplant.
Primary disease Frequency (%)
Glomerulonephritis 19
Renal dysplasia 18
Posterior urethral valves 16
Reflux nephropathy 12
Systemic lupus erythematosis 9
Polycystic kidney disease 7
Glomerulosclerosis 7
Other 12
Table I. Causes of renal failure in 149 transplanted children
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91% at 1 year and 80% at 5 years, but then starts dropping off 
at 7 years to 72% (Figs 4 and 5). Patient survival during this 
period is 96% at 1 year and 88% at 5 years.
This compares favourably with paediatric figures elsewhere; 
patients transplanted from 1993 to 1995 in the UK5 have a 1-
year graft survival of 79% and a 5-year survival of 68%, and 
North American6 5-year graft survival was 73% for cadaveric 
and 81% for living-donor recipients over the same time period.
Mortality in the group transplanted in the last 10 years 
(1995 - 2005) was 8/89 (9%). Causes of death include sepsis in 
3 cases (2 of CMV and 1 of Gram-negative sepsis), recurrence 
of primary disease in 2 (focal segmental glomerulosclerosis), 
non-compliance with chronic rejection in 3 and hepatitis B 
infection in 1. 
Surgical complications were few and included vascular 
thrombosis leading to graft loss in 2/89 cases (2.3%), 
ureteric leak in 1 case (successfully repaired), and 3 cases 
of vesicoureteric reflux (VUR) with recurrent urinary tract 
infections (requiring re-implantation of ureter).
In the light of our small donor pool3 the HLA matching of 
our cadaver transplants in our paediatric patients was poor, 
with 60/89 (68%) of our patients having 5 or more mismatches 
out of 6.
Immunosuppression
Drugs used by our patients include azathioprine (40%), 
tacrolimus (25%), cyclosporin (24%), MMF (6%) and Rapamycin 
(5%). We have used similar proportions of both cyclosporin 
(49%) and tacrolimus (51%). Cyclosporin is significantly cheaper 
than tacrolimus and for cost-effectiveness this has been our first-
line agent. In our paediatric patients on cyclosporin, cosmetic 
side-effects including hirsutism and gum hypertrophy have 
been significant problems. This together with rejection episodes 
has resulted in conversion to tacrolimus in individual cases. 
Tacrolimus was implicated in diabetes mellitus in 8/131(6%) 
paediatric transplants (5 renal and 3 liver) currently being 
followed-up by our unit. Mean age at transplant was 10 years 
4 months and mean age at diagnosis 11 years. Patients who 
developed diabetes had common risk factors: high body mass 
index, previously high dosage of steroids and high mean trough 
tacrolimus level of 10.4 ng/ml. There was also an increased 
incidence in our black patients  – 4/8 (50%) patients who 
developed diabetes were black despite this group being only 
28/89 (31%) of our total programme.
MMF is increasingly being used as a calcineurin-sparing 
agent but diarrhoea has been a significant problem especially 
in adolescent patients. If tolerated, we have reduced our 
cyclosporin to achieve trough levels less than 50 ng/ml and 
tacrolimus to less than 5 ng/ml. In 3 cases we have successfully 
stopped calcineurin drugs and have maintained their grafts on 
MMF and low-dose alternate-day steroids only.
Rapamycin has also been used as a calcineurin-sparing agent 
but we have seen many of the side-effects described including 
high cholesterol (50%), interstitial pneumonitis (2 cases), severe 
bone-marrow suppression with thrombocytopenia and bleeding 
tendency (1 case) and proteinuria (2 cases). We have not had 
problems of delayed wound healing, as we have not used this 
agent in the early post-transplant period.
 IL2 receptor blockers have been increasingly used as 
induction agents, especially in view of our poor HLA matching. 
This resulted in an acute rejection rate of only 3/16 (18.8%) 
compared with historic controls of 16/23 (70%). There has 
therefore been a significantly overall shorter stay in hospital 
with the potential to use lower doses of steroids. Long-term 
graft survival still remains to be seen. When comparing the 
drugs used, no rejection was noted in 4/7 cases on basiliximab 
and 9/9 cases on daclizumab, suggesting that daclizumab in 
our setting appears to have a better outcome, but this needs 
larger studies.  
















































TB represents a significant problem. During the period 
1996 - 2004, the incidence of TB was 7/72 (9.7%) in our 
transplant patients. Presentation was 10 months to 8 years 
post transplant with symptoms of fever and cough in all and 
weight loss in most. No patients were on prophylaxis. With 
the exception of one renal case, the rest all had pulmonary TB 
with pericardial involvement in 2 cases. Immunosuppression 
at the time of diagnosis consisted of cyclosporin, azathioprine 
and prednisone.  Diagnosis was made on finding acid-fast 
bacilli using a combination of sputum, nasogastric aspirate 
and bronchial lavage. In one case, a fine-needle aspirate of the 
lung produced the acid-fast bacilli. All the cases were typically 
mycobacterium TB and fully sensitive to rifampicin and 
INH.  Three cases had had an increased dose of steroids in the 
preceding 3 months. An increased cyclosporin dose (up to 5 
times) was required once starting the rifampicin. All cases were 
successfully treated with no loss of patient or graft. 
Fatal CMV infection was seen in a 13-year-old girl with 
renal dysplasia and Fanconi’s anaemia who received a 
CMV-mismatched organ (donor CMV positive: recipient 
CMV negative) in February 2001. Prophylactic intravenous 
ganciclovir was given for 2 weeks, but unfortunately she 
developed a pneumonia requiring ventilation 11 months later 
and died of CMV pneumonia.  
EBV-driven post-transplant lymphoproliferative disorder 
(PTLD) was seen in 1 renal transplant who presented with a 
nodal mass in his inguinal region. Immunosuppression was 
reduced and ganciclovir and rituximab (anti-CD 20 agent) were 
given together with chemotherapy. Therapy remains successful 
together with preserved renal function.
Other serious infections in this group of patients have 
included disseminated varicella with transverse myelitis, 
Pneumocystis jiroveci pneumonia and cat scratch disease 
(Bartonella henselae). All were treated successfully and retained 
their grafts. 
Vaccinations
Audit of vaccination status in a group of 32 cases with age 
range 93 - 225 months (mean 148 months) reviewed post 
transplant found protective immunity to hepatitis A (53% 
patients), hepatitis B (19% patients) and varicella (72% 
patients).
Adolescent transplant transition
We have had difficulty with transition of adolescents to adult 
units in the last 10 years with 5 adolescents having lost their 
grafts and 2 dying within 1 year of transfer despite adequate 
renal function at time of transfer. We have good 1- and 5-year 
graft and patient survival but our long-term outcome in the 
adolescent age group is significantly worse than in younger 
transplant recipients, as is reported universally.
Discussion
Paediatric transplantation poses numerous challenges, not only 
the conventional problems of acute rejection and infection, but 
also technically creative surgery to accommodate the significant 
size range (our group ranged from 8 kg to 63 kg) of paediatric 
patients. There may be further challenges in a developing 
country including difficult social circumstances, poor HLA 
matching (68% of our patients had 5 or more mismatches) as 
well as a limited number of donors exacerbated by the high 
incidence of HIV infection. In order to try and increase our 
donor pool, we may need to expand the current pool of living 
related donors (24%) beyond just the parents and potentially 
also consider non-heart-beating donors.
Whereas previously acute rejection was our biggest concern, 
this has now become easier to manage, by using the newer 
immunosuppressant agents including induction with IL2 
receptor blockers. Our acute rejection rate has reduced to 18.8% 
using 2 initial doses of IL2 receptor blockers (both basiliximab 
and daclizumab used in 2-dosing regimen). Despite the initial 
cost of this form of therapy, these agents have allowed us to 
use an overall cheaper immunosuppressive protocol (such 
as cyclosporin and azathioprine) in our setting where cost 
containment is important. 
However, the consequences of increased immunosuppression 
and reduced rejection are increased infection; this is highlighted 
by problems such as CMV infection or EBV-driven PTLD. This 
is particularly a problem in the young patient with no previous 
CMV or EBV exposure who receives a donor organ-recipient 
mismatch. The advent of qualitative and, more recently, 
quantitative polymerase chain reaction (PRC) testing will have 
a significant impact on both monitoring and management 
of these viruses. Intravenous ganciclovir is costly and 
inconvenient and hopefully prophylaxis will be made easier 
with the introduction of the oral valganciclovir form. As yet no 
vaccines are available for these two viruses.
TB is endemic in our region – our rate of TB in paediatric 
transplant patients was 9.7% – and together with HIV infection, 
raises issues of drug resistance, choice and duration of 
prophylactic agents.6 Our patients developed TB 10 months 
to 8 years post transplant and it would thus be futile using 
prophylaxis for TB in the first 6 months only. Drug interactions 
between anti-TB drugs and immunosuppressants are also a 
concern.
On review of the vaccination status in a small group of 
our patients, hepatitis B levels were low post transplant with 
Varicella rates best overall. Paediatric studies have shown loss 
of antibodies to vaccinations within 6 months post-transplant.7
Awareness of adequate vaccination pre-transplant, specifically 
live-attenuated vaccines, with regular post-transplant 
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In an established paediatric programme, with 1- and 5-year 
results which are  satisfactory by international paediatric 
standards, despite all the problems of a developing country, 
emphasis on long-term graft and patient survival becomes 
an important focus. In view of this, we have tried to limit 
nephrotoxicity often caused by calcineurin inhibitors by using 
renal-sparing immunosuppressants. MMF has been useful 
in reducing dosing or even ceasing calcineurin inhibitors 
completely in those with chronic allograft nephropathy8 and 
we have managed to use MMF and steroids as dual therapy 
only, with stable renal function so far in 3 of our patients. 
Sirolimus has also been well described as a renal-sparing 
agent,9 but we have seen a significant number of drug-
related side-effects including interstitial pneumonitis and 
thrombocytopenia with purpura. In 2 cases we have noticed 
unexplained new-onset proteinuria, which has been described 
by a few centres as a concern. 
In those patients on calcineurin inhibitors, cyclosporin has 
been responsible for significant cosmetic effects (hirsuitism and 
gum hypertrophy). These patients have usually been changed 
to tacrolimus therapy but this has also had problems of 
diabetes in 6% of our renal transplant in which 50% were black 
paediatric patients (relatively higher incidence than that of the 
total programme which consists of 31% black patients).
Children’s growth in paediatric transplantation has received 
much attention recently and this is particularly important at a 
centre where growth hormone is not easily available. Steroids 
as immunosuppression have attracted negative press recently. 
In response to this, there have been three main approaches: (i)
steroid elimination or avoidance in the first place12 with use 
of heavier immunosuppression such as a prolonged course of 
daclizumab; (ii) steroid withdrawal in those who had steroids 
at time of transplant;13 or (iii) steroid preservation at low 
dosing. We use the last approach using low-dose (0.05 mg/
kg/day) alternate-day steroids. A recent review by Marks and 
Trompeter14 also encouraged steroid preservation to prevent 
exchanging acute rejection for infection including EBV/
PTLD. They suggest that steroids remain superior to many 
other immunosuppressive drugs in terms of cost and past 
experience, suggesting that it may be more sensible to remove 
calcineurin inhibition.
Long-term outcomes are greatly affected by adolescent 
issues and this is clearly seen by our results at 1 and 5 years 
compared with the group more than 7 years post transplant 
(Figs 4 and 5). This is notoriously the most difficult group 
of patients to follow up, a problem for colleagues in both 
paediatric and adult units alike, and we have this in common 
with the rest of the world.15 This is particularly problematic 
where resources are limited, with adolescent issues similar 
to those in developed countries, but different economic 
constraints resulting in patients not being offered repeat 
dialysis or transplant.  
In response to our poor long-term graft survival in 
adolescence, we have set up a combined transplant clinic with 
our adult and paediatric team based at the adult unit. This 
includes social support in the form of psychiatrists, nurses and 
social workers. 
Challenges in the transition period include overcoming the 
fear of an unknown hospital, adjusting to a different patient/
doctor ratio and increased independence in terms of their own 
health care. The move is preceded by psychological input in 
the form of workshops and one-to-one interviews prior to 
transfer to the adult unit. 
We also delay the transfer to at least 16 years of age and 
often even older until patients are mature enough to do the 
transition with their independence established. Preparation of 
our younger adolescents, involving them in their own renal 
function results and medication adjustments, is also important 
with a positive goal of seeing transition to an adult unit as 
a successful ‘graduation’ process. A ‘champion’ on the adult 
service is required – be that a nurse or a doctor – so that the 
patients feel comfortable at the time of transfer by identifying 
a familiar face involved with them throughout the transition 
period.
Other factors affecting long-term outcome also depend on 
decreasing cardiovascular risk factors by reduction of steroid 
dosing, careful attention to body mass index to prevent obesity 
and inclusion of statins where necessary.
Despite all the challenges of a developing country, a 
successful paediatric transplant programme is possible, 
provided one is aware of all the pitfalls including infection, 
nephrotoxic drugs and adolescent transition.
Thanks to Jeanette Raad for statistical assistance.
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